<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04898478</url>
  </required_header>
  <id_info>
    <org_study_id>R34DA049989</org_study_id>
    <nct_id>NCT04898478</nct_id>
  </id_info>
  <brief_title>Intervention Development and Pilot Study to Prevent Untreated Native Hawaiian and Pacific Islander Opioid Use Disorder</brief_title>
  <official_title>Intervention Development and Pilot Study to Prevent Untreated Native Hawaiian and Pacific Islander Opioid Use Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Riverside</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Riverside</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will design and pilot/feasibility test a culturally grounded intervention to&#xD;
      increase the treatment seeking of Pacific Islanders with opioid use disorders in formal&#xD;
      services.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the clinical trial arm of this pilot/feasibility study, the investigators will conduct a&#xD;
      pilot/feasibility test of our conceptual model of culturally grounded intervention components&#xD;
      with 20 Pacific Islander adults with experience with opioid use disorders, then conduct 2&#xD;
      focus groups per site to finalize the components and items for larger R01 pilot and&#xD;
      randomized wait-list controlled testing.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2023</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pacific Islander Knowledge Scale about Opioid Use Disorders and Treatment</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>5-point scale designed by the team to assess Pacific Islander knowledge of opioid use disorder and treatment with items such as &quot;What causes most OUDs? What are the different treatment options for PIs with OUDs&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pacific Islander Attitude Scale about Opioid Use Disorders and Treatment</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>10-point scale designed by the team to assess Pacific Islander attitudes toward opioid use disorder treatment such as &quot;How important is treatment?&quot; and &quot;How scary is treatment?&quot;</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Opioid-use Disorder</condition>
  <arm_group>
    <arm_group_label>Treatment Seeking Intervention for Pacific Islanders with Opioid Use Disorders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will consist of a behavioral intervention to increase treatment seeking among Pacific Islanders with opioid use disorders.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Treatment Seeking Intervention for Pacific Islanders with Opioid Use Disorders</intervention_name>
    <description>The investigators will design a culturally grounded treatment seeking intervention for Pacific Islanders with OUDs</description>
    <arm_group_label>Treatment Seeking Intervention for Pacific Islanders with Opioid Use Disorders</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Of Pacific Islander/Native Hawaiian or part-Pacific Islander/Native Hawaiian heritage.&#xD;
&#xD;
          -  Live in Utah or Hawaii.&#xD;
&#xD;
          -  For all lay Pacific Islander adult participants: must be over 18 years of age.&#xD;
&#xD;
          -  Fluent (oral and reading) in English or Native Hawaiian.&#xD;
&#xD;
        For target Pacific Islander participants with OUDs, additional inclusion criteria is:&#xD;
&#xD;
        - Presence of active OUD, as screened via 8-item Rapid Opioid Dependence Scale.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Do not meet inclusion criteria,&#xD;
&#xD;
          -  Are unwilling to participate,&#xD;
&#xD;
          -  Fails to provide or retracts consent,&#xD;
&#xD;
          -  Reside outside the target communities of Utah or Hawaii&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrew Subica</last_name>
    <phone>8089369806</phone>
    <email>asubica@medsch.ucr.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UC Riverside</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>91784</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Subica</last_name>
      <phone>808-936-9806</phone>
      <email>asubica@medsch.ucr.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2021</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Opioid-Related Disorders</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

